IDiyas

For the Inventor, By the Inventor

Wachenheim, Germany

Horst Kreiskott

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal13 out of 10,754 
 
Basf Aktiengesellschaft
 patents

Years Active: 1980-1986

Loading Chart...
13 patents (USPTO):
1. 4619929 - Phenylpiperazine derivatives of hetarylphenols and hetarylanilines, (1986-10-28),
2. 4618622 - Sulfonates of hydroxycoumarins (1986-10-21),
3. 4610818 - N-acyl derivatives of dipeptides, their preparation and their use in the (1986-09-09),
4. 4610817 - N-acyl derivatives of peptides, their preparation and their use in the (1986-09-09),
5. 4596820 - 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane for use in the treatment (1986-06-24),
6. 4564641 - Substituted (1986-01-14),
7. 4548933 - Sedative compositions containing (1985-10-22),
8. 4499087 - 7-Phenyl-7-phenoxymethyl-hexahydro-1,4-oxazepines and their use (1985-02-12),
9. 4447610 - 10-Substituted 5-cyanomethylene-dibenzo[A,B]-cycloheptenes, their (1984-05-08),
10. 4388237 - 6(1-Piperazinyl), piperidino and (1(homopiperazinyl)11-cyanomethylene (1983-06-14),
11. 4376773 - 10-Substituted (1983-03-15),
12. 4362727 - 5-Substituted 9-cyanomethylene-dithieno[3,4-b:4,3-e]-azepines and (1982-12-07),
13. 4183935 - Bispidine derivatives, their preparation, and drugs containing same (1980-01-15),

Title: Horst Kreiskott: Innovator in Pharmaceutical Chemistry

Introduction

Horst Kreiskott is a notable inventor based in Wachenheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Kreiskott's latest patents include innovative derivatives such as phenylpiperazine derivatives of hetarylphenols and hetarylanilines. These compounds exhibit predominantly sedative, neuroleptic, and hypotensive properties. Another significant patent involves sulfonates of hydroxycoumarins, which are designed for use as drugs, showcasing his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Kreiskott has been associated with BASF Aktiengesellschaft, a leading chemical company. His work has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry. His innovative approaches have led to the development of compounds that are crucial for various therapeutic applications.

Collaborations

Kreiskott has collaborated with esteemed colleagues such as Hans P Hofmann and Gerd Steiner. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Horst Kreiskott's contributions to pharmaceutical chemistry through his numerous patents highlight his role as an influential inventor. His innovative work continues to impact the field positively, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…